Á lódáil...
Rho kinase inhibitors for treatment of glaucoma
Affecting 60 million patients, glaucoma is the second leading cause of blindness worldwide. Despite the availability of multiple medical and surgical treatments with effective intraocular pressure lowering, many patients still progress to become visually handicapped from glaucoma due to therapeutic...
Na minha lista:
| Foilsithe in: | Expert Rev Ophthalmol |
|---|---|
| Main Authors: | , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
2014
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6319899/ https://ncbi.nlm.nih.gov/pubmed/30613208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/eop.11.65 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|